QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A.
Nevertheless, Manchester’s life sciences cluster has bounced back and evolved following AstraZeneca’s departure, Sheppard ...
Automation solutions bring these processes together into seamless and cost-effective workflows. QIAGEN serves over 500,000 ...
Mammalian genomes are organized by multi-level folding, yet how this organization contributes to cell type-specific transcription remain unclear. We uncovered that the nuclear protein SATB1 ...
QIAGEN N.V. (NYSE: QGEN ... commercial development for our products to customers in the Life Sciences and clinical healthcare, changes in relationships with customers, suppliers or strategic ...
The germany DNA polymerase market is set for significant expansion, with projections indicating a rise from USD 20.7 million in 2025 to USD 40.0 million by 2035, driven by a 6.8% CAGR. As a leading ...
DelveInsight's In Situ Hybridization Market Insights report provides the current and forecast market analysis, individual ...
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard ... The company serves more than 500,000 customers globally across Life Sciences and Molecular Diagnostics and employs over 5,700 people in over ...